Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2014

Open Access 01-12-2014 | Research article

Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study

Authors: Emmy Okello, Andrea Beaton, Charles K Mondo, Paul Kruszka, Noah Kiwanuka, Richard Odoi-Adome, Juergen Freers

Published in: BMC Cardiovascular Disorders | Issue 1/2014

Login to get access

Abstract

Background

Rheumatic heart disease (RHD), the only long term consequence of acute rheumatic fever, remains a leading cause of morbidity and mortality among young adults in Uganda. An inherited susceptibility to acute rheumatic fever centers around the major histocompatibility class II human leucocyte antigens. However, there is paucity of data from sub-Saharan Africa. This study compares the frequency of HLA class II DR alleles between RHD cases and normal controls in Uganda.

Methods

One hundred ninety-nine participants including 96 established RHD cases aged 5–60 years and 103 age and sex matched normal controls were recruited for participation. DNA was manually extracted from buffy coat samples and HLA analysis was performed. HLA-DR allelic frequency comparison between cases and controls were estimated using conditional logistic regression with 95% confidence intervals. P -values were corrected for multiple hypothesis testing.

Results

199 participants (103 female, 51.8%) completed the study. The mean (SD) age in years for cases and controls were 29.6 (10.2) and 29(18), respectively. After conditional logistic regression and multiple hypothesis testing, HLA-DR1was associated with a decreased risk of RHD (OR = 0.42, CI 0.21-085, P = 0.01, Corrected P value (PC) = 0.09,) while HLA-DR11 was associated with increased risk of RHD (OR = 3.31, CI 1.57-6.97, P = <0.001, Pc < 0.001). No other significant associations were found.

Conclusion

In this first study of HLA genetic susceptibility to RHD in Uganda, HLA- DR1 was more common in normal controls while HLA- DR11 was more common among RHD cases suggesting a disease susceptibility association. In future studies, high resolution HLA analysis and genome wide studies should be carried out to confirm this pattern.
Literature
1.
go back to reference Paar J, Berrios NM, Rose JD, Caderes M, Pena R, Perez W, Chen-Mok M, Jolles E, Dale JB: Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol. 2010, 105: 1809-14. 10.1016/j.amjcard.2010.01.364.CrossRefPubMedPubMedCentral Paar J, Berrios NM, Rose JD, Caderes M, Pena R, Perez W, Chen-Mok M, Jolles E, Dale JB: Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol. 2010, 105: 1809-14. 10.1016/j.amjcard.2010.01.364.CrossRefPubMedPubMedCentral
2.
go back to reference Omurzakova NA, Yamano Y, Saatova GM, Mirzakhanova MI, Shukurova SM, Kydyralieva RB, Jumagulova AS, Seisenbaev ASh, Nishioka K, Nakajima T: High incidence of rheumatic fever and rheumatic heart disease in the republics of Central Asia. Int J Rheum Dis. 2009, 2: 79-83.CrossRef Omurzakova NA, Yamano Y, Saatova GM, Mirzakhanova MI, Shukurova SM, Kydyralieva RB, Jumagulova AS, Seisenbaev ASh, Nishioka K, Nakajima T: High incidence of rheumatic fever and rheumatic heart disease in the republics of Central Asia. Int J Rheum Dis. 2009, 2: 79-83.CrossRef
3.
go back to reference Agarwal B: Rheumatic Heart Disease unabated in developing countries. Lancet. 1981, 24: 910-911.CrossRef Agarwal B: Rheumatic Heart Disease unabated in developing countries. Lancet. 1981, 24: 910-911.CrossRef
4.
go back to reference Kayima J, Mungoma M, Mondo C, Freers J: The changing pattern of cardiac disease in Africa: the Ugandan experience. Cardiovasc J Afr. 2011, 22 (3): S9- Kayima J, Mungoma M, Mondo C, Freers J: The changing pattern of cardiac disease in Africa: the Ugandan experience. Cardiovasc J Afr. 2011, 22 (3): S9-
5.
go back to reference Bryant PA, Robins-Browne R, Carapetis JR, Curtis N: Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation. 2009, 119 (5): 742-53. 10.1161/CIRCULATIONAHA.108.792135.CrossRefPubMed Bryant PA, Robins-Browne R, Carapetis JR, Curtis N: Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation. 2009, 119 (5): 742-53. 10.1161/CIRCULATIONAHA.108.792135.CrossRefPubMed
6.
go back to reference Quinn A, Weber K, Fischetti VA, Hemric M, Cunningham MW: Immunological relationship between the class I epitope of streptococcal M protein and myosin. Infect Immun. 1998, 66: 4418-24.PubMedPubMedCentral Quinn A, Weber K, Fischetti VA, Hemric M, Cunningham MW: Immunological relationship between the class I epitope of streptococcal M protein and myosin. Infect Immun. 1998, 66: 4418-24.PubMedPubMedCentral
7.
go back to reference Engel ME, Stander R, Vogel J, Adeyemo AA, Mayosi BM: Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS ONE. 2011, 6 (9): e25326-10.1371/journal.pone.0025326.CrossRefPubMedPubMedCentral Engel ME, Stander R, Vogel J, Adeyemo AA, Mayosi BM: Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS ONE. 2011, 6 (9): e25326-10.1371/journal.pone.0025326.CrossRefPubMedPubMedCentral
8.
go back to reference Ayoub E: Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest. 1986, 77 (6): 2019-26. 10.1172/JCI112531.CrossRefPubMedPubMedCentral Ayoub E: Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest. 1986, 77 (6): 2019-26. 10.1172/JCI112531.CrossRefPubMedPubMedCentral
9.
go back to reference Guadalupe H-P: Jose´Aguilar-Garcı´ab, Carmina Flores-Domı´nguezb: MHC class II alleles in Mexican patients with rheumatic heart disease. Int J Cardiol. 2003, 92: 49-54. 10.1016/S0167-5273(03)00040-8.CrossRef Guadalupe H-P: Jose´Aguilar-Garcı´ab, Carmina Flores-Domı´nguezb: MHC class II alleles in Mexican patients with rheumatic heart disease. Int J Cardiol. 2003, 92: 49-54. 10.1016/S0167-5273(03)00040-8.CrossRef
10.
go back to reference Kudat H, Telci G, Sozen AB, Oguz F, Akkaya : The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int J Immunogenet. 2006, 33 (1): 41-44. 10.1111/j.1744-313X.2006.00562.x.CrossRefPubMed Kudat H, Telci G, Sozen AB, Oguz F, Akkaya : The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int J Immunogenet. 2006, 33 (1): 41-44. 10.1111/j.1744-313X.2006.00562.x.CrossRefPubMed
11.
go back to reference Carlquist JF, Ward RH, Meyer KJ, Husebye D, Feolo M, Anderson JL: Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles. J Am Coll Cardiol. 1995, 26: 452-7. 10.1016/0735-1097(95)80022-9.CrossRefPubMed Carlquist JF, Ward RH, Meyer KJ, Husebye D, Feolo M, Anderson JL: Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles. J Am Coll Cardiol. 1995, 26: 452-7. 10.1016/0735-1097(95)80022-9.CrossRefPubMed
12.
go back to reference Chou HT, Chen CH, Chen JY, Chang KC: Association of HLA DRB1-DQA1-DQB1 haplotypes with rheumatic heart disease in Taiwan. Int J Cardiol. 2008, 128 (3): 434-435. 10.1016/j.ijcard.2007.06.032.CrossRefPubMed Chou HT, Chen CH, Chen JY, Chang KC: Association of HLA DRB1-DQA1-DQB1 haplotypes with rheumatic heart disease in Taiwan. Int J Cardiol. 2008, 128 (3): 434-435. 10.1016/j.ijcard.2007.06.032.CrossRefPubMed
13.
go back to reference Remenyi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabela M, Mocumbi AO, Mota C, Paar J, Saxena A, Scheel J, Stirling J, Viali S, Balekundri BI, Wheaton G, Zuhlke L, Carapetis J: World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol. 2012, 9: 297-309. 10.1038/nrcardio.2012.7.CrossRefPubMed Remenyi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabela M, Mocumbi AO, Mota C, Paar J, Saxena A, Scheel J, Stirling J, Viali S, Balekundri BI, Wheaton G, Zuhlke L, Carapetis J: World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol. 2012, 9: 297-309. 10.1038/nrcardio.2012.7.CrossRefPubMed
14.
go back to reference Vahanian M, Baumgartner H, Bax J, Alfieri O, Antunes MJ, Andreotti F, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A: Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007, 28: 230-PubMed Vahanian M, Baumgartner H, Bax J, Alfieri O, Antunes MJ, Andreotti F, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A: Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007, 28: 230-PubMed
15.
go back to reference Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992, 39 (5): 225-35. 10.1111/j.1399-0039.1992.tb01940.x.CrossRefPubMed Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992, 39 (5): 225-35. 10.1111/j.1399-0039.1992.tb01940.x.CrossRefPubMed
16.
go back to reference Zetterquist H, Olerup O: Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol. 1992, 34 (1): 64-67.CrossRefPubMed Zetterquist H, Olerup O: Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol. 1992, 34 (1): 64-67.CrossRefPubMed
17.
go back to reference Lauritsen JM, Bruus M: A comprehensive tool for validated entry and documentation of data. 2006, Odense Denmark: The EpiData Association, EpiData Entry (3.0) Lauritsen JM, Bruus M: A comprehensive tool for validated entry and documentation of data. 2006, Odense Denmark: The EpiData Association, EpiData Entry (3.0)
18.
go back to reference Gündogdu F, Islamoglu Y, Pirim I, Gurlertop Y, Dogan H: Human leukocyte antigen (HLA) class I and II alleles in Turkish patients with rheumatic heart disease. J Heart Valve Dis. 2007, 16 (3): 293-9.PubMed Gündogdu F, Islamoglu Y, Pirim I, Gurlertop Y, Dogan H: Human leukocyte antigen (HLA) class I and II alleles in Turkish patients with rheumatic heart disease. J Heart Valve Dis. 2007, 16 (3): 293-9.PubMed
19.
go back to reference Maharaj B, Hammond MG, Appadoo B, Leary BWP, Pudifin DJ: HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation. 1987, 76: 259-61. 10.1161/01.CIR.76.2.259.CrossRefPubMed Maharaj B, Hammond MG, Appadoo B, Leary BWP, Pudifin DJ: HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation. 1987, 76: 259-61. 10.1161/01.CIR.76.2.259.CrossRefPubMed
20.
go back to reference Haydardedeoğlu FE, Tutkak H, Köse K, Düzgün N: Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR alleles. Tissue Antigens. 2006, 68 (4): 293-296. 10.1111/j.1399-0039.2006.00678.x.CrossRefPubMed Haydardedeoğlu FE, Tutkak H, Köse K, Düzgün N: Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR alleles. Tissue Antigens. 2006, 68 (4): 293-296. 10.1111/j.1399-0039.2006.00678.x.CrossRefPubMed
21.
go back to reference Cao K, Moormann AM, Lyke KE, Masaberg C, Sumba OP: Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens. 2004, 4 (63): 293-325.CrossRef Cao K, Moormann AM, Lyke KE, Masaberg C, Sumba OP: Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens. 2004, 4 (63): 293-325.CrossRef
22.
go back to reference Kijak GH, Walsh AM, Koehler RN, Moqueet N, Eller LA, Eller M: HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster. Tissue Antigens. 2009, 3 (73): 262-9.CrossRef Kijak GH, Walsh AM, Koehler RN, Moqueet N, Eller LA, Eller M: HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster. Tissue Antigens. 2009, 3 (73): 262-9.CrossRef
23.
go back to reference El-Hagrassy N, El-Chennawi F, Zaki M-S, Fawzy H, Zaki A, Joseph N: HLA class I and class II HLA DRB profiles in Egyptian children with rheumatic valvular disease. Pediatr Cardiol. 2010, 5 (31): 650-6.CrossRef El-Hagrassy N, El-Chennawi F, Zaki M-S, Fawzy H, Zaki A, Joseph N: HLA class I and class II HLA DRB profiles in Egyptian children with rheumatic valvular disease. Pediatr Cardiol. 2010, 5 (31): 650-6.CrossRef
24.
go back to reference Bajoria D, Menon T: The HLA Class II Associations with Rheumatic Heart Disease in South Indian Patients: a preliminary study. J Clin Diagn Res. 2013, 2 (7): 302-304. Bajoria D, Menon T: The HLA Class II Associations with Rheumatic Heart Disease in South Indian Patients: a preliminary study. J Clin Diagn Res. 2013, 2 (7): 302-304.
25.
go back to reference Guédez Y, Kotby A, El-Demellawy M, Galal A, Thomson G, Zaher S, Kassem S, Kotb M: HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation. 1999, 21 (99): 2784-2790.CrossRef Guédez Y, Kotby A, El-Demellawy M, Galal A, Thomson G, Zaher S, Kassem S, Kotb M: HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation. 1999, 21 (99): 2784-2790.CrossRef
Metadata
Title
Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study
Authors
Emmy Okello
Andrea Beaton
Charles K Mondo
Paul Kruszka
Noah Kiwanuka
Richard Odoi-Adome
Juergen Freers
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2014
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-14-28

Other articles of this Issue 1/2014

BMC Cardiovascular Disorders 1/2014 Go to the issue